Proto Labs Inc — Institutional Ownership
Which tracked institutions hold PRLB, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
24
Funds holding
$375267015
Total value held
Buying
19 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $209712432 | 3677875 | +58871 | +1.63% |
| 2 | State Street Corp | $62265840 | 1092000 | +3794 | +0.35% |
| 3 | Prudential Financial Inc | $22821742 | 400241 | +217415 | +118.92% |
| 4 | Morgan Stanley | $16740055 | 293581 | -12031 | -3.94% |
| 5 | Northern Trust Corp | $15221546 | 266951 | +10683 | +4.17% |
| 6 | Goldman Sachs Group Inc | $8036569 | 140943 | -19661 | -12.24% |
| 7 | Bank Of New York Mellon Corp | $7978096 | 139917 | -3078 | -2.15% |
| 8 | Principal Financial Group Inc | $7618613 | 133613 | -3057 | -2.24% |
| 9 | Bank Of America Corp /De/ | $7362023 | 129113 | +35784 | +38.34% |
| 10 | Invesco Ltd. | $5448441 | 107698 | +5364 | +5.24% |
| 11 | Ameriprise Financial Inc | $3337893 | 58539 | +9822 | +20.16% |
| 12 | Franklin Resources Inc | $3247802 | 56959 | +24022 | +72.93% |
| 13 | Wells Fargo & Company/Mn | $1516385 | 29974 | +8141 | +37.29% |
| 14 | Citigroup Inc | $774685 | 15313 | -6824 | -30.83% |
| 15 | Royal Bank Of Canada | $745000 | 13059 | — | NEW BUY |
| 16 | Janus Henderson Group Plc | $692877 | 12160 | — | NEW BUY |
| 17 | Sei Investments Co | $502858 | 8819 | — | NEW BUY |
| 18 | Barclays Plc | $300439 | 5269 | — | NEW BUY |
| 19 | Fifth Third Bancorp | $292455 | 5129 | +4988 | +3537.59% |
| 20 | Raymond James Financial Inc | $277915 | 4874 | +223 | +4.79% |
| 21 | Bank Of Montreal /Can/ | $240396 | 4216 | — | NEW BUY |
| 22 | Pnc Financial Services Group, Inc. | $111646 | 1958 | +14 | +0.72% |
| 23 | Us Bancorp \De\ | $20641 | 362 | +35 | +10.70% |
| 24 | Amalgamated Financial Corp. | $666 | 12599 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.